trophos Pages on BioPortfolio:

Trophos starts Phase II Clinical Trial of TRO19622 in Liver Disease
15 May 2008 ... Trophos is a biopharmaceutical company committed to the discovery ... The Trophos discovery strategy has enabled it to develop a portfolio ...
http://www.bioportfolio.com/biotech_news/Trophos_12.htm...

Trophos strengthens management team with key appointments
New appointments in the Trophos product development team include the arrival of ... Dr Berna joins Trophos after successive positions in project management ...
http://www.bioportfolio.com/biotech_news/Trophos_2.htm...

Trophos successfully completes phase 1 clinical trials for novel ...
31 Jan 2006 ... Trophos successfully completes phase 1 clinical trials for novel compound to treat neurodegenerative diseases.
http://www.bioportfolio.com/biotech_news/Trophos_1.htm...

Trophos appoints Damian Marron as Chief Executive Officer
Marseille, June 12th, 2008 - Trophos SA, a biopharmaceutical company specializing in the discovery and development of drugs for neurological
disorders, ...
http://www.bioportfolio.com/biotech_news/Trophos_14.htm...

Trophos describes analgesic activity of neuroprotective agent ...
Trophos describes analgesic activity of neuroprotective agent TRO19622 in preclinical models of painful peripheral neuropathy.
http://www.bioportfolio.com/biotech_news/Trophos_13.htm...

Trophos Starts Phase Ib Clinical Trial of TRO19622 in Spinal ...
Trophos is currently enrolling patients in a European Phase IIa trial to assess ... The successful completion of these Phase Ib studies will enable Trophos, ...
http://www.bioportfolio.com/biotech_news/Trophos_9.htm...

Trophos will start Phase II clinical trial in diabetic neuropathy ...
Trophos will start Phase II clinical trial in diabetic neuropathy after successful completion of preclinical studies.
http://www.bioportfolio.com/biotech_news/Trophos_5.htm...

Trophos SA and CHDI, Inc. extend partnership to develop promising ...
Trophos SA and CHDI, Inc. extend partnership to develop promising compounds in models relevant to Huntington disease.
http://www.bioportfolio.com/biotech_news/Trophos_6.htm...

Trophos Appoints Jacques Essinger as President of Supervisory Board
30 May 2006 ... Dr Essinger, 45, brings Trophos a wealth of experience in ... "I am pleased to join the Trophos Supervisory Board and to be working with ...
http://www.bioportfolio.com/biotech_news/Trophos_4.htm...

BioPortfolio - Trophos SA
Trophos SA - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/31276-Trophos_SA.ht...

Results from other life science and pharmaceutical sites:

Welcome to Trophos' homepage, drug discovery & development company ...
Trophos is a biopharmaceutical company developing drugs to prevent neuronal loss in patients with neurodegenerative disease.
http://www.trophos.com/...

Trophos: Management
Trophos' management team comes from both biotech and the pharmaceutical industry : ... Prior to joining Trophos he was Executive Vice President, ...
http://www.trophos.com/corporate/management.htm...

Trophos: Board
Supervisory Board. Marc Villecroze (President), Director of Participations of Viveris Management, management company of the innovation mutual fund Innoveris
...
http://www.trophos.com/corporate/board.htm...

BioPortfolio - Trophos SA
Trophos SA - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/31276-Trophos_SA.ht...

Trophos: Press Archives
Trophos describes identification, characterization and broad neuroprotective properties of TRO19622 in Journal of Pharmacology and Experimental Therapeutics
...
http://www.trophos.com/news/prarchives.htm...

Trophos: Press Release 27 Feb 2006
27 Feb 2006 ... Marseille, February 27, 2006 - Trophos SA, a biopharmaceutical company specializing in the discovery and development of drugs for ...
http://www.trophos.com/news/pr20060227.htm...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.